Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:31:38.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:27:32.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:55:21.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:49:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page has updated the status of the clinical trial to 'Active, not recruiting' and added new relevant dates, while removing outdated information and a previous contact name.
    Difference
    2%
    Check dated 2025-04-23T22:33:24.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed information about a clinical trial for Pembrolizumab in patients with Adrenocortical Carcinoma, and the addition of a new version revision and collaborators.
    Difference
    45%
    Check dated 2025-04-16T14:58:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.